BRISTOL MYERS SQUIBB CO (BMY)
Clinical trial NCT05651932: enrollment: 125 → 165 participants.
Clinical trial NCT05651932: enrollment: 125 → 165 participants.
Clinical trial NCT05503264 updates: 1. completion date: 2029-12-14 → 2028-12-14 2. enrollment: 152 → 120 participants
Clinical trial NCT07298044 updates: 1. completion date: 2027-12-25 → 2027-07-15 2. primary completion date: 2027-12-25 → 2027-07-15
Clinical trial NCT06523569 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. completion date: 2026-06-30 → 2026-12-01 3. primary completion date: 2026-06-30 → 2026-12-01
Clinical trial NCT05870579: status: ACTIVE_NOT_RECRUITING → RECRUITING.
Clinical trial NCT06006962 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. enrollment: 128 → 134 participants 3. enrollment type: ESTIMATED → ACTUAL
Clinical trial NCT04586049 updates: 1. completion date: 2026-06-01 → 2026-12-01 2. primary completion date: 2026-06-01 → 2026-12-01
Clinical trial NCT02846987 updates: 1. completion date: 2026-07-01 → 2027-07-01 2. primary completion date: 2026-07-01 → 2027-07-01
Clinical trial NCT04793776 updates: 1. completion date: 2026-06-30 → 2026-12-30 2. primary completion date: 2026-06-01 → 2026-10-01
Clinical trial NCT07178730: start date: 2026-01-31 → 2026-06-30.